Susquehanna International Group, LLP Harmony Biosciences Holdings, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$28.81 - $33.01 $374,530 - $429,130	13,000 Added 48.51%	39,800 $1.2 Million
Q1 2024 May 07, 2024	BUY	$29.93 - $35.06 $317,258 - $371,636	10,600 Added 65.43%	26,800 $899,000
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $904,320 - $1.59 Million	-47,100 Reduced 74.41%	16,200 $523,000
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $873,786 - $1.07 Million	27,400 Added 76.32%	63,300 $2.07 Million
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $475,800 - $583,440	15,600 Added 76.85%	35,900 $1.26 Million
Q1 2023 May 16, 2023	BUY	$30.8 - $53.92 $625,240 - $1.09 Million	20,300 New	20,300 $662,000
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $126,180 - $166,350	3,000 Added 50.85%	8,900 $394,000

228

45.4M

48.2K

61.5K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.32B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.